ONO-8711 is primarily used in research settings to study its effects on prostaglandin receptors, particularly EP1 receptors. It acts as a selective antagonist, making it valuable for investigating the role of these receptors in various physiological and pathological processes. Researchers utilize ONO-8711 to explore its potential in managing pain, inflammation, and other conditions linked to prostaglandin signaling. Its application extends to preclinical studies aimed at understanding its therapeutic potential in diseases such as cancer, neurological disorders, and cardiovascular conditions. By blocking EP1 receptors, ONO-8711 helps elucidate the mechanisms underlying these conditions and contributes to the development of targeted treatments.